| PERIOD ENDING | 27-Jul-08 | 27-Apr-08 | 27-Jan-08 | 28-Oct-07 | | Total Revenue | 892,676 | 1,153,388 | 1,202,730 | 1,115,597 | | Cost of Revenue | 742,759 | 638,545 | 653,133 | 600,044 | | | Gross Profit | 149,917 | 514,843 | 549,597 | 515,553 | | | Operating Expenses | | Research Development | 212,910 | 218,830 | 195,835 | 179,529 | | Selling General and Administrative | 92,399 | 93,034 | 91,263 | 88,183 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (155,392) | 202,979 | 262,499 | 247,841 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 8,792 | 10,039 | 17,457 | 18,958 | | Earnings Before Interest And Taxes | (146,600) | 213,018 | 279,956 | 266,799 | | Interest Expense |
-
|
-
| 54 |
-
| | Income Before Tax | (146,600) | 213,018 | 279,902 | 266,799 | | Income Tax Expense | (25,671) | 36,213 | 22,909 | 31,138 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (120,929) | 176,805 | 256,993 | 235,661 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (120,929) | 176,805 | 256,993 | 235,661 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($120,929) | $176,805 | $256,993 | $235,661 |
|
1.49% Nasdaq 
0.27%
Income Statement
